Description:
A drug used to treat adults with follicular lymphoma that came back or did not get better after treatment with at least two other types of systemic therapy. It is also being studied in the treatment of other types of cancer. Mosunetuzumab binds to a protein called CD3, which is found on T cells (a type of white blood cell). It also binds to a protein called CD20, which is found on B cells (another type of white blood cell) and some lymphoma cells. This may help the immune system kill cancer cells. Mosunetuzumab is a type of bispecific monoclonal antibody. Also called Lunsumio.
